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Late Coronary Occlusion After
Intracoronary Brachytherapy
Marco A. Costa, MD; Manel Sabate´, MD; Wim J. van der Giessen, MD, PhD; I. Patrick Kay, MBChB;
Pavel Cervinka, MD; Jurgen M.R. Ligthart, BSc; Pedro Serrano, MD; Veronique L.M.A. Coen, MD;
Peter C. Levendag, MD, PhD; Patrick W. Serruys, MD, PhD
Background—Intracoronary brachytherapy appears to be a promising technology to prevent restenosis. Presently, limited
data are available regarding the late safety of this therapeutic modality. The aim of the study was to determine the
incidence of late (.1 month) thrombosis after PTCA and radiotherapy.
Methods and Results—From April 1997 to March 1999, we successfully treated 108 patients with PTCA followed
by intracoronary b-radiation. Ninety-one patients have completed at least 2 months of clinical follow-up. Of these
patients, 6.6% (6 patients) presented with sudden thrombotic events confirmed by angiography 2 to 15 months after
intervention (2 balloon angioplasty and 4 stent). Some factors (overlapping stents, unhealed dissection) may have
triggered the thrombosis process, but the timing of the event is extremely unusual. Therefore, the effect of radiation
on delaying the healing process and maintaining a thrombogenic coronary surface is proposed as the most plausible
mechanism to explain such late events.
Conclusions—Late and sudden thrombosis after PTCA followed by intracoronary radiotherapy is a new phenomenon
in interventional cardiology. (Circulation. 1999;100:789-792.)
Key Words: thrombosis n angioplasty n radioisotopes
Thrombotic occlusion after PTCA is associated withincreased morbidity and mortality rates.1 Current tech-
niques of stenting followed by antiplatelet therapy have
dramatically reduced the incidence of this event to ,1.5%.2,3
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Intracoronary radiation is a promising new therapy to
prevent restenosis. Recent randomized trials demonstrated
a reduction in the restenosis rate and maintenance of
benefits up to 2-year follow-up.4 – 6 Presently, limited data
are available regarding long-term safety after intracoro-
nary brachytherapy.5,7 Although subacute thrombosis has
been reported after radiotherapy,4,8 –9 the incidence of late
thrombotic events has not been determined.
The aim of this study was to document the incidence of
late (.1 month) thrombotic events after elective PTCA
followed by intravascular radiotherapy.
Methods and Results
From April 1997 to March 1999, 108 consecutive patients
were successfully treated with catheter-based intracoronary
b-radiation at the Thoraxcenter (Rotterdam, The Nether-
lands). The Medical Ethical Committee approved the use of
radiation therapy and informed consent was obtained from
every patient. All patients presented with stable angina
pectoris and single vessel disease. Brachytherapy was per-
formed using the Beta-Cath system (Novoste Corporation)10
(n576 patients, 32 stents and 44 balloon angioplasty [BA]),
or the Guidant intravascular brachytherapy system (Guidant
Corporation Vascular Intervention)11 (n532 patients, 13
Stents and 19 BA). BA and stenting were performed accord-
ing to standard techniques. Intravascular ultrasound (IVUS)
was performed after radiation with a mechanical ultrasound
catheter (CVIS, Boston Scientific). Off-line quantitative cor-
onary angiography was performed using CAAS system (Pie
Medical Imaging BV). Six-month angiographic and IVUS
follow-up was scheduled in all patients.
All patients were discharged without complications. Ninety-
one patients completed at least 2-month clinical follow-up. We
observed 1 case of subacute thrombosis occurring 15 days after
stenting. This patient received an 18-mm long stent (postdilated
at 10 atm) with optimal IVUS result. Ticlopidine withdrawal (12
days after stenting) was the plausible explanation of thrombosis
in this case.
Six patients (6.6%) presented with sudden late throm-
botic coronary occlusion. Two of them were treated with
BA and the remaining 4 received an additional stent after
radiation. Their clinical characteristics are summarized in
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the Table. No clinical or anatomic characteristic appeared
to be related to these events.
In patient 1, overlapping 9- and 32-mm NIR stents
(Medinol Ltd) were optimally implanted as assessed by
IVUS. Patients 2 and 3 (BA) showed type B dissections
without compromising flow postprocedure. Patients 4
and 5 both received a Multilink 25-mm stent (Advanced
Cardiovascular Systems/Guidant), and patient 6 received a
NIR 16-mm stent with optimal angiographic results. Stent
patients were discharged on aspirin (250 mg/d) and ticlo-
pidine (250 mg BID for 15 days in patients 3 and 4, and for
30 days in cases 5 and 6). BA patients received aspirin
alone.
Patient 1 was readmitted with ventricular fibrillation 2
months after the procedure, whereas, patients 2, 5, and 6
sustained inferior myocardial infarctions (MI) between 2.5
and 3 months after the treatment. The irradiated segment
was occluded at 6-month angiogram in patients 1 and 2
(Figure 1). Thrombotic occlusion was successfully treated
by primary angioplasty in patients 5 and 6.
In patient 3, the 6-month IVUS control revealed a
persistent (unhealed) submedial dissection (Figure 2) with
no signs of restenosis. Nine months later, this patient
sustained a posterolateral MI which was treated with
thrombolytics. Two weeks after this treatment, an angio-
gram performed because of recurrent angina showed the
occlusion in the irradiated area. Similarly, the 6-month
IVUS control of patient 4 showed no neointimal hyperpla-
sia. Four months after control, she had a stroke and aspirin
was replaced by acenocoumarol. Ten days later, she
sustained an anterior MI. The thrombotic occlusion in the
treated site was confirmed by angiography.
Discussion
Progression to total occlusion after BA is a stable process in
the general nonirradiated population which occurs in approx-
imately 4% of patients, leading to a MI in ,0.5%.12 In
contrast, our study shows a high incidence (6.6%) of throm-
botic clinical events 2 to 15 months after PTCA and
brachytherapy.
Coronary dissection after BA is associated with abrupt
closure; however, type B dissections (NHLBI classifica-
tion), as observed after BA in our patients, have not been
related to thrombotic events.13 The normal healing process,
present after dissections, may be impaired after intracoro-
Clinical and Angiographic Variables
Variables 1 2 3 4 5 6
Age, y 57 58 49 73 52 62
Sex Male Female Male Female Female Female
Pre-procedure
Target vessel LCX RCA LCX LAD RCA RCA
Type of lesion B B B A A B
RD, mm 2.5 2.8 2.67 2.66 2.84 2.6
MLD, mm 0.9 1.12 0.64 1.09 0.65 0.55
DS, % 66 60 76 60 77 78
Lesion length, mm 13 15 18 11.2 9.6 9.7
Procedure
Brachytherapy system Beta-Cath Guidant Beta-Cath Beta-Cath Beta-Cath Beta-Cath
Source length, mm 30 27 30 30 30 30
Prescribed dose, Gy 12* 35† 12* 14* 18* 14*
Stent/angioplasty Stent Balloon Balloon Stent Stent Stent
Total stent length, mm 41 25 25 16
Postprocedure
Dissection/type No Yes/B Yes/B No No No
MLD, mm 2.47 2.07 2.15 2.4 2.34 2.4
DS, % 21 26 21 9.5 17 7
Clinical success Yes Yes Yes Yes Yes Yes
Follow-up
Event VF Inferior MI Postlateral MI Anterior MI Inferior MI Inferior MI
Time, mo 2 3 15 10 3 2.5
Antiplatelet medication Yes Yes Yes No Yes Yes
Associated factors Long stent Dissection Dissection at 6-mo Aspirin withdrawal No No
LCX indicates left circumflex artery; RCA, right coronary artery; LAD, left anterior descending artery; RD, reference diameter; MLD,
minimal lumen diameter; DS, diameter stenosis; VF, ventricular fibrillation; and MI, myocardial infarction.
*At 2 mm from the source; †at 0.5 mm into the vessel wall.
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nary radiation.14 Whether unhealed dissections, as demon-
strated in patient 3, is related to late thrombosis remains to
be elucidated in a larger population. Further, the necessity
of stenting mild dissections without compromising flow
after radiotherapy should be investigated.
The mean time of subacute thrombosis after stenting is
approximately 5 to 6 days.2,3 In a recent study, subacute
thrombosis occurred within the first 24 hours in 86% of
patients treated with aspirin and ticlodipine for 14 days,
with no case of thrombotic events occurring after 15
days.15 Colombo et al reported only 2 cases (0.6%) of
thrombosis occurring 2 to 6 months after stenting.2 In
contrast, in our study, 4 patients receiving a stent (8.8%)
experienced thrombosis late after radiation.
Experimentally, reendothelialization after injury takes
.4 weeks to be completed.16 However, the clinical pre-
sentation of subacute thrombosis infrequently occurs later
than 15 days after stenting,15 when the reendothelialization
process may still be incomplete. Delayed reendotheli-
alization as a trigger mechanism of late stent thrombosis
after antineoplastic therapy has been hypothesized previ-
ously.17 Farb et al reported incomplete endothelialization 3
months after placement of b-radioactive stent.18 Neverthe-
less, the same group showed no differences regarding
endothelial cell growth between radioactive and control
stents in another experimental model.19 Further studies
should address the timing of stent reendothelialization
after brachytherapy to determine its role on the pathogen-
esis of late thrombosis.
Although multiple stents have been related to subacute
thrombosis,20 the significance of multiple stent implanta-
tion (patient 1) on late thrombotic phenomena has not been
demonstrated.
The use of intracoronary b-radiation is a common
feature in our patients. However, the judgment of whether
radiation is the key factor in the pathogenesis of late
thrombosis should await the analysis of ongoing trials.
Concomitantly, the benefit of prolonged antiplatelet ther-
apy with the combination of aspirin, clopidogrel, or
ticlopidine should be considered.
Limitations
Our patients were included in well-controlled b-radiation
studies with similar baseline characteristics and inclusion
criteria (lesion length ,15 mm, treatment of single vessel).
However, 2 different systems to deliver b-radiation were
used.
In addition, it is not possible to rule out the natural
history of coronary disease as a cause of late thrombosis.
However, the incidence of total occlusion in the general
nonirradiated population is much lower than that observed
in our study. In fact, the incidence of late thrombotic
events would be even higher if, in the interest of complete-
ness, we waited for 1-year follow-up in the total patient
population.
Finally, whether late thrombosis is a generic complica-
tion of intracoronary radiotherapy or is restricted to the use
of b-sources cannot be extrapolated from our findings.
Figure 1. Patient 1. A, Preprocedure
angiography shows a significant lesion in
the mid-third of left circumflex artery. B,
Radioactive source placed in treated site.
C, Postprocedure angiography and IVUS
images show an optimal result (arrow-
heads). D, At 2 months, the proximal part
of stent appeared occluded.
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Figure 2. Patient 3. A, Postprocedure coronary dissection, demonstrated both on angiography and IVUS, did not compromise flow in
treated area (arrowhead). B, This dissection persisted unhealed at 6-month control (arrowhead). C, At 15 months, irradiated segment
appeared occluded.
792 Circulation August 24, 1999
